KCNQ2 and Ataxia: Thus, much like retigabine activation of KCNQ2/3, Kv1 current augmentation by small molecules such as gallic acid would be expected to dampen excess neural excitability and potentially ameliorate ataxia even if Kv1 channel dysfunction was not the original cause.